1: Huml L, Jurášek M, Mikšátková P, Zimmermann T, Tomanová P, Buděšínský M, Rottnerová Z, Šimková M, Harmatha J, Kmoníčková E, Lapčík O, Drašar PB. Immunoassay for determination of trilobolide. Steroids. 2017 Jan;117:105-111. doi: 10.1016/j.steroids.2016.08.019. Epub 2016 Sep 4. PubMed PMID: 27600788.
2: Škorpilová L, Rimpelová S, Jurášek M, Buděšínský M, Lokajová J, Effenberg R, Slepička P, Ruml T, Kmoníčková E, Drašar PB, Wimmer Z. BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide. Beilstein J Org Chem. 2017 Jul 4;13:1316-1324. doi: 10.3762/bjoc.13.128. eCollection 2017. PubMed PMID: 28781697; PubMed Central PMCID: PMC5530629.
3: Jurášek M, Džubák P, Rimpelová S, Sedlák D, Konečný P, Frydrych I, Gurská S, Hajdúch M, Bogdanová K, Kolář M, Müller T, Kmoníčková E, Ruml T, Harmatha J, Drašar PB. Trilobolide-steroid hybrids: Synthesis, cytotoxic and antimycobacterial activity. Steroids. 2017 Jan;117:97-104. doi: 10.1016/j.steroids.2016.08.011. Epub 2016 Aug 17. PubMed PMID: 27543674.
4: Tomanová P, Rimpelová S, Jurášek M, Buděšínský M, Vejvodová L, Ruml T, Kmoníčková E, Drašar PB. Trilobolide-porphyrin conjugates: on synthesis and biological effects evaluation. Steroids. 2015 May;97:8-12. doi: 10.1016/j.steroids.2014.08.024. Epub 2014 Sep 6. PubMed PMID: 25204594.
5: Harmatha J, Buděšínský M, Vokáč K, Kostecká P, Kmoníčková E, Zídek Z. Trilobolide and related sesquiterpene lactones from Laser trilobum possessing immunobiological properties. Fitoterapia. 2013 Sep;89:157-66. doi: 10.1016/j.fitote.2013.05.025. Epub 2013 Jun 5. PubMed PMID: 23747321.
6: Jurášek M, Rimpelová S, Kmoníčková E, Drašar P, Ruml T. Tailor-made fluorescent trilobolide to study its biological relevance. J Med Chem. 2014 Oct 9;57(19):7947-54. doi: 10.1021/jm500690j. Epub 2014 Sep 17. PubMed PMID: 25197766.
7: Harmatha J, Vokáč K, Buděšínský M, Zídek Z, Kmoníčková E. Immunobiological properties of sesquiterpene lactones obtained by chemically transformed structural modifications of trilobolide. Fitoterapia. 2015 Dec;107:90-99. doi: 10.1016/j.fitote.2015.10.002. Epub 2015 Oct 22. PubMed PMID: 26474674.
8: Wictome M, Holub M, East JM, Lee AG. The importance of the hydroxyl moieties for inhibition of the Ca(2+)-ATPase by trilobolide and 2,5-di(tert-butyl)-1,4-benzohydroquinone. Biochem Biophys Res Commun. 1994 Mar 15;199(2):916-21. PubMed PMID: 8135840.
9: Kmoníčková E, Harmatha J, Vokáč K, Kostecká P, Farghali H, Zídek Z. Sesquiterpene lactone trilobolide activates production of interferon-γ and nitric oxide. Fitoterapia. 2010 Dec;81(8):1213-9. doi: 10.1016/j.fitote.2010.08.005. Epub 2010 Aug 19. PubMed PMID: 20727953.
10: Harmatha J, Buděšínský M, Jurášek M, Zimmermann T, Drašar P, Zídek Z, Kmoníčková E, Vejvodová L. Structural modification of trilobolide for upgrading its immunobiological properties and reducing its cytotoxic action. Fitoterapia. 2019 Apr;134:88-95. doi: 10.1016/j.fitote.2019.02.002. Epub 2019 Feb 4. PubMed PMID: 30731148.
11: Oliver SF, Högenauer K, Simic O, Antonello A, Smith MD, Ley SV. A route to the thapsigargins from (S)-carvone providing a substrate-controlled total synthesis of trilobolide, nortrilobolide, and thapsivillosin F. Angew Chem Int Ed Engl. 2003 Dec 15;42(48):5996-6000. PubMed PMID: 14679553.
12: Rimpelová S, Jurášek M, Peterková L, Bejček J, Spiwok V, Majdl M, Jirásko M, Buděšínský M, Harmatha J, Kmoníčková E, Drašar P, Ruml T. Archangelolide: A sesquiterpene lactone with immunobiological potential from Laserpitium archangelica. Beilstein J Org Chem. 2019 Aug 13;15:1933-1944. doi: 10.3762/bjoc.15.189. eCollection 2019. PubMed PMID: 31501660; PubMed Central PMCID: PMC6720059.
13: Huang X, Ou S, Tang S, Fu L, Wu J. Simultaneous determination of trilobolide-6-O-isobutyrates A and B in Wedelia trilobata by gas chromatography. Se Pu. 2006 Sep;24(5):499-502. PubMed PMID: 17165548.
14: Wictome M, Khan YM, East JM, Lee AG. Binding of sesquiterpene lactone inhibitors to the Ca(2+)-ATPase. Biochem J. 1995 Sep 15;310 ( Pt 3):859-68. PubMed PMID: 7575419; PubMed Central PMCID: PMC1135975.
15: Rasmussen U, Christensen SB, Sandberg F. Phytochemistry of the genus Thapsia. Planta Med. 1981 Dec;43(4):336-41. PubMed PMID: 17402057.
16: Søhoel H, Jensen AM, Møller JV, Nissen P, Denmeade SR, Isaacs JT, Olsen CE, Christensen SB. Natural products as starting materials for development of second-generation SERCA inhibitors targeted towards prostate cancer cells. Bioorg Med Chem. 2006 Apr 15;14(8):2810-5. Epub 2006 Jan 10. PubMed PMID: 16412648.
17: Andrews SP, Ball M, Wierschem F, Cleator E, Oliver S, Högenauer K, Simic O, Antonello A, Hünger U, Smith MD, Ley SV. Total synthesis of five thapsigargins: guaianolide natural products exhibiting sub-nanomolar SERCA inhibition. Chemistry. 2007;13(20):5688-712. PubMed PMID: 17508363.
18: Christensen SB, Hergenhahn M, Roeser H, Hecker E. Toxicodynamics of tumour promoters of mouse skin. III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay. J Cancer Res Clin Oncol. 1992;118(5):344-8. PubMed PMID: 1533861.
19: Thomson LJ, Hall JL, Williams LE. A Study of the Effect of Inhibitors of the Animal Sarcoplasmic/Endoplasmic Reticulum-Type Calcium Pumps on the Primary Ca2+-ATPases of Red Beet. Plant Physiol. 1994 Apr;104(4):1295-1300. PubMed PMID: 12232168; PubMed Central PMCID: PMC159293.